Tobramycin Export Market Intelligence: India's 283 Suppliers Shipping to 134 Countries — TransData Nexus 2026

Q: Who are the top tobramycin exporters from India?

The top tobramycin exporters from India are: 1. MANKIND PHARMA LIMITED — $8.1M (20.7% market share); 2. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $6.4M (16.2% market share); 3. SENTISS PHARMA PRIVATE LIMITED — $4.5M (11.4% market share); 4. GLAND PHARMA LTD — $3.4M (8.6% market share); 5. MYLAN LABORATORIES LIMITED — $2.8M (7.2% market share). Together they account for 64.0% of India's total tobramycin export value.

Q: What is the total export value of tobramycin from India?

The total export value of tobramycin from India is $39.2M USD, recorded across 2,676 shipment transactions from 283 active exporters to 134 destination countries. The average shipment value is $14.7K.

Q: Which countries import tobramycin from India?

India exports tobramycin to 134 countries worldwide. The top importing countries are: UNITED STATES (62.3% share, $24.5M), RUSSIA (15.3% share, $6.0M), BELGIUM (8.8% share, $3.5M), AUSTRALIA (4.0% share, $1.6M), VIETNAM (1.7% share, $668.4K). These five markets account for 92.2% of total export value.

Q: What is the HS code for tobramycin exports from India?

The primary HS code for tobramycin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of tobramycin exports from India?

The average unit price for tobramycin exports from India is $6.32 USD per unit, with prices ranging from $0.02 to $1782.19 depending on formulation, packaging, and order volume. The total market is valued at $39.2M across 2,676 shipments.

Q: Which ports handle tobramycin exports from India?

The primary ports for tobramycin exports from India are DELHI AIR CARGO ACC (INDEL4) (17.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (12.3% of shipments), DELHI AIR (11.8% of shipments), SAHAR AIR (11.1% of shipments), NHAVA SHEVA SEA (INNSA1) (3.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of tobramycin?

India is one of the world's leading exporters of tobramycin due to its large base of 283 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports tobramycin to 134 countries, demonstrating 69% global market coverage.

Q: What certifications do Indian tobramycin exporters need?

Indian tobramycin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import tobramycin from India?

There are 580 registered buyers importing tobramycin from India, spread across 134 countries. The repeat buyer rate is 51.7%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top tobramycin supplier from India?

MANKIND PHARMA LIMITED is the leading tobramycin exporter from India with a market share of 20.7% and total export value of $8.1M across 78 shipments. The top 5 suppliers together control 64.0% of total export value.

Suresh Sormare

Tobramycin

India Pharmaceutical Trade Intelligence

$39.2M283 Suppliers134 CountriesHS 30049099

ExportsIndia → UNITED STATES62.3%India → RUSSIA15.3%

ImportsUNITED STATES → India$498.0K CHINA → India$88.3K

#1 Supplier: MANKIND PHARMA #1 Buyer: LIFESTAR PHARMA

Tobramycin Export Analysis | Transdata Nexus | TransData Nexus

How India Exports Tobramycin to the World

Between 2022 and 2026, India exported $39.2M worth of tobramycin across 2,676 verified shipments to 134 countries — covering 69% of world markets in the Antibiotics segment. The largest destination is UNITED STATES (62.3%). MANKIND PHARMA LIMITED leads with a 20.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Tobramycin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Tobramycin export data snapshot — $39.2M · 283 exporters · 134 countriesTransData Nexus · Indian Customs Data

Top Tobramycin Exporters from India

283 active exporters · Ranked by export value

View all 283 →

Top Tobramycin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MANKIND PHARMA LIMITED	$8.1M	78	2	20.7%
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED

Top Countries Importing Tobramycin from India

134 destination markets · Ranked by import value

All 134 countries →

Top Countries Importing Tobramycin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$24.5M	62.3%
2	RUSSIA	$6.0M	15.3%
3	BELGIUM	$3.5M	8.8%
4	AUSTRALIA	$1.6M	4.0%
5	VIETNAM	$668.4K	1.7%
6	CANADA	$609.9K	1.6%
7	PHILIPPINES	$262.3K	0.7%
8	CHILE	$211.2K	0.5%
9	KAZAKHSTAN	$170.1K	0.4%
10	VENEZUELA	$165.2K	0.4%

UNITED STATES is India's largest tobramycin export destination, absorbing 62.3% of total exports worth $24.5M. The top 5 importing countries — UNITED STATES, RUSSIA, BELGIUM, AUSTRALIA, VIETNAM — together account for 92.2% of India's total tobramycin export value. The remaining 129 destination countries collectively receive the other 7.8%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Tobramycin to India?

9 origin countries · Total import value: $618.8K

India imports tobramycin from 9 countries with a combined import value of $618.8K. The largest supplier is UNITED STATES ($498.0K, 61 shipments), followed by CHINA and HUNGARY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Tobramycin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$498.0K	61	80.5%
2	CHINA	$88.3K	2	14.3%
3	HUNGARY	$20.0K	1	3.2%
4	LATVIA	$5.7K	3	0.9%
5	FRANCE	$3.7K	1	0.6%
6	CANADA	$1.8K	2	0.3%
7	AUSTRIA	$592	1	0.1%
8	UNITED KINGDOM	$415	1	0.1%
9	TAIWAN	$245	1	0.0%

UNITED STATES is the largest supplier of tobramycin to India, accounting for 80.5% of total import value. The top 5 origin countries — UNITED STATES, CHINA, HUNGARY, LATVIA, FRANCE — together supply 99.5% of India's tobramycin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Tobramycin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Tobramycin, an aminoglycoside antibiotic, has been approved in the United States through multiple Abbreviated New Drug Applications (ANDAs). The FDA's Orange Book lists several approved generic versions, indicating a well-established market presence. Notably, the FDA has not issued any import alerts specific to tobramycin, suggesting compliance with regulatory standards among exporters. The primary regulatory pathway for tobramycin involves the submission of an ANDA, demonstrating bioequivalence to the reference listed drug. Given that 62.3% of India's tobramycin exports are destined for the United States, the absence of import alerts underscores the adherence of Indian exporters to FDA requirements.

2EU & UK Regulatory Framework

In the European Union, tobramycin has been authorized for various indications. For instance, Tobi Podhaler received marketing authorization on July 20, 2011, for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in cystic fibrosis patients aged six years and older. Similarly, Vantobra was authorized on February 18, 2019, for the same indication. These approvals necessitate compliance with the European Medicines Agency's (EMA) Good Manufacturing Practice (GMP) guidelines, ensuring product quality and safety. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, requiring similar GMP compliance for tobramycin products.

3WHO Essential Medicines & Global Standards

Tobramycin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its significance in treating priority health conditions. The 24th edition, published in September 2025, lists tobramycin as an essential medicine. This inclusion reflects its critical role in healthcare systems worldwide. Additionally, tobramycin formulations are standardized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, tobramycin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for tobramycin, allowing market-driven pricing. For export purposes, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products; however, tobramycin is not currently listed among those requiring an export NOC, facilitating its international trade.

5Patent & Exclusivity Status

The primary patents for tobramycin have expired, leading to a competitive generic market. This expiration has enabled multiple manufacturers to produce and export tobramycin, contributing to the substantial export figures from India. The presence of 283 active Indian exporters and a repeat buyer rate of 51.7% further illustrates the robust competition and sustained demand in the global market.

6Recent Industry Developments

In May 2025, the WHO updated its Model List of Essential Medicines, reaffirming tobramycin's inclusion, which may influence procurement policies globally. In July 2025, the EMA approved a new generic version of tobramycin, enhancing market competition within the EU. In September 2025, the NPPA conducted a review of antibiotic pricing, though tobramycin's price remained unregulated, allowing market dynamics to dictate its cost. In November 2025, the FDA issued guidance on the manufacturing of aminoglycoside antibiotics, emphasizing compliance with current Good Manufacturing Practices (cGMP), which is pertinent to tobramycin producers. In January 2026, the CDSCO announced a streamlined process for the export of antibiotics, potentially benefiting tobramycin exporters by reducing bureaucratic hurdles.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Tobramycin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, renowned for its generic formulations, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70% of APIs used in Indian drug manufacturing are sourced from China, with certain critical KSMs being almost exclusively produced there. This dependency exposes the supply chain to significant risks, as disruptions in Chinese manufacturing—due to environmental regulations, geopolitical tensions, or other factors—can lead to shortages and increased costs for Indian pharmaceutical companies.

The COVID-19 pandemic underscored these vulnerabilities when Chinese factory shutdowns caused immediate API shortages, affecting global drug supplies. In response, the Indian government launched the Production Linked Incentive (PLI) scheme in October 2024, aiming to bolster domestic API and KSM production. This initiative led to the inauguration of two greenfield plants dedicated to manufacturing essential molecules like Penicillin G and 6-Aminopenicillanic acid (6-APA), marking a significant step toward reducing import dependence.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Tobramycin from India account for 64.0% of the total export value, with MANKIND PHARMA LIMITED alone contributing 20.7%. This high supplier concentration poses a risk, as disruptions affecting these key players could significantly impact global Tobramycin availability. While the PLI scheme has initiated efforts to diversify and strengthen domestic API production, the full impact on reducing supplier concentration remains to be seen.

Access Complete Tobramycin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,676 transactions across 134 markets.

Request Demo View Pricing

Frequently Asked Questions — Tobramycin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top tobramycin exporters from India?

The leading tobramycin exporters from India are MANKIND PHARMA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SENTISS PHARMA PRIVATE LIMITED, and 11 others. MANKIND PHARMA LIMITED leads with 20.7% market share ($8.1M). The top 5 suppliers together control 64.0% of total export value.

What is the total export value of tobramycin from India?

The total export value of tobramycin from India is $39.2M, recorded across 2,676 shipments from 283 active exporters to 134 countries. The average shipment value is $14.7K.

Which countries import tobramycin from India?

India exports tobramycin to 134 countries. The top importing countries are UNITED STATES (62.3%), RUSSIA (15.3%), BELGIUM (8.8%), AUSTRALIA (4.0%), VIETNAM (1.7%), which together account for 92.2% of total export value.

What is the HS code for tobramycin exports from India?

The primary HS code for tobramycin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Tobramycin

Tobramycin

How India Exports Tobramycin to the World

Top Tobramycin Exporters from India

Top Countries Importing Tobramycin from India

Who Supplies Tobramycin to India?

Quick Facts

Related Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Tobramycin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Tobramycin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Tobramycin Trade Intelligence

Frequently Asked Questions — Tobramycin Exports from India

Who are the top tobramycin exporters from India?

What is the total export value of tobramycin from India?

Which countries import tobramycin from India?

What is the HS code for tobramycin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of tobramycin exports from India?

Which ports handle tobramycin exports from India?

Why is India a leading exporter of tobramycin?

What certifications do Indian tobramycin exporters need?

How many buyers import tobramycin from India?

What is the market share of the top tobramycin exporter from India?

Analysis Methodology